WWC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62447832963153E-12 |
Normal-vs-Stage2 |
1.63458135915562E-12 |
Normal-vs-Stage3 |
4.71844785465692E-14 |
Normal-vs-Stage4 |
9.56649999994674E-07 |
Stage1-vs-Stage2 |
8.276800E-01 |
Stage1-vs-Stage3 |
8.893800E-01 |
Stage1-vs-Stage4 |
6.543000E-01 |
Stage2-vs-Stage3 |
9.343800E-01 |
Stage2-vs-Stage4 |
5.940200E-01 |
Stage3-vs-Stage4 |
5.546800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
1.55431223447522E-15 |
Normal-vs-Asian |
1.0858999999197E-07 |
Caucasian-vs-AfricanAmerican |
3.441400E-01 |
Caucasian-vs-Asian |
3.731000E-01 |
AfricanAmerican-vs-Asian |
3.086400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
1.62436730732907E-12 |
Male-vs-Female |
4.781900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.62525548574877E-12 |
Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
Normal-vs-Obese |
3.33066907387547E-16 |
Normal-vs-Extreme_Obese |
5.25235410719915E-12 |
Normal_Weight-vs-Extreme_Weight |
4.429400E-01 |
Normal_Weight-vs-Obese |
3.004200E-01 |
Normal_Weight-vs-Extreme_Obese |
6.944200E-01 |
Extreme_Weight-vs-Obese |
2.781600E-02 |
Extreme_Weight-vs-Extreme_Obese |
8.458200E-01 |
Obese-vs-Extreme_Obese |
1.602190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.38050032411275E-10 |
Normal-vs-Age(41-60Yrs) |
<1E-12 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
9.99910154675376E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.353800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.380000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.874760E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.916500E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.924230E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.593000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
Normal-VS-Type2 PRCC |
1.62458935193399E-12 |
Normal-VS-KIRP CIMP |
7.02979999767095E-08 |
Normal-VS-Unclassified PRCC |
5.38820099649229E-11 |
Type1 PRCC-VS-Type2 PRCC |
9.632400E-02 |
Type1 PRCC-VS-KIRP CIMP |
9.189800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
1.182390E-01 |
Type2 PRCC-VS-KIRP CIMP |
3.785600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.682280E-02 |
KIRP CIMP-VS-Unclassified PRCC |
4.561000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.32827124036339E-15 |
Normal-vs-N1 |
3.05680003531705E-09 |
Normal-vs-N2 |
2.11719974885227E-10 |
N0-vs-N1 |
1.860970E-01 |
N0-vs-N2 |
2.585800E-01 |
N1-vs-N2 |
1.721570E-02 |
|
|